Related Experiment Video
Updated: Nov 3, 2025
Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
Characterization of a putative maltodextrin-binding protein of Streptococcus pyogenes, SPs0871 and the development of
Tsukushi Yamawaki1, Makoto Nakakido2, Kan Ujiie3
1Department of Chemistry & Biotechnology, School of Engineering, The University of Tokyo, Bunkyo-ku, Tokyo, 113-8656, Japan.
Abstract:
Streptococcus pyogenes causes a wide range of human infections. Currently, antibiotics are the main treatment for S. pyogenes infection, but serious anti-microbial resistance requires alternative treatment options. To develop a novel strategy for treatment, we physicochemically characterized SPs0871, a putative maltose/maltodextrin-binding protein that is thought to have important roles in the pathogenesis of invasive streptococci. We obtained a variable domain of heavy chain of heavy-chain antibody, the smallest unit of an antibody, which specifically binds to SPs0871. Although the VHH completely inhibited the binding of maltodextrins to SPs0871, the inhibition did not lead to growth suppression of the bacteria. Our results provide important insights for development of VHH as an anti-streptococcal therapeutic.
Insights
Researchers explored a novel therapeutic strategy against Streptococcus pyogenes by targeting the SPs0871 protein. While a specific antibody fragment (VHH) blocked protein binding, it did not inhibit bacterial growth, offering insights for future anti-streptococcal treatments.
Area of Science:
- Microbiology
- Immunology
- Drug Discovery
Background:
- Streptococcus pyogenes infections are a significant public health concern, with rising antibiotic resistance necessitating alternative therapeutic approaches.
- The SPs0871 protein, a putative maltose/maltodextrin-binding protein, is implicated in the pathogenesis of invasive streptococcal diseases.
- Novel treatment strategies are crucial to combat the increasing challenge of antimicrobial resistance in S. pyogenes infections.
Purpose of the Study:
- To investigate the potential of targeting the SPs0871 protein as a novel therapeutic strategy against Streptococcus pyogenes.
- To physicochemically characterize SPs0871 and assess the inhibitory effects of a specific VHH antibody fragment.
- To evaluate the impact of inhibiting SPs0871 function on bacterial growth and pathogenesis.
Main Methods:
- Physicochemical characterization of the SPs0871 protein from Streptococcus pyogenes.
- Generation and isolation of a variable domain of heavy chain of heavy-chain antibody (VHH) that specifically binds to SPs0871.
- Assay to evaluate the inhibition of maltodextrin binding to SPs0871 by the VHH fragment.
- Bacterial growth assays to determine the effect of VHH-mediated inhibition on S. pyogenes proliferation.
Main Results:
- A VHH antibody fragment was successfully generated, demonstrating specific binding to the SPs0871 protein.
- The VHH fragment effectively inhibited the binding of maltodextrins to SPs0871.
- Despite complete inhibition of maltodextrin binding, the VHH treatment did not result in the suppression of S. pyogenes bacterial growth.
- These findings highlight a complex role for SPs0871 in bacterial pathogenesis beyond simple nutrient binding.
Conclusions:
- The study provides valuable insights into the function of SPs0871 in Streptococcus pyogenes.
- While targeting SPs0871 with VHH antibodies can block specific protein interactions, it does not directly inhibit bacterial growth.
- Further research is warranted to explore the therapeutic potential of VHH antibodies and to understand the broader role of SPs0871 in streptococcal infections for developing novel anti-streptococcal agents.
